HOLX
Hologic, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$76.01
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+1.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Apr 9, 2026 | Oberton Karleen Marie · officer: Chief Financial Officer | A-Award | 42,707 | $0.00 |
| Apr 9, 2026 | COHN BENJAMIN JORDAN · officer: Principal Accounting Officer | A-Award | 5,665 | $0.00 |
| Apr 9, 2026 | Horvath Mark W. · officer: President, Breast & Skeletal | A-Award | 7,762 | $0.00 |
| Apr 9, 2026 | MACMILLAN STEPHEN P · director, officer: Chairman, President and CEO | A-Award | 190,400 | $0.00 |
| Apr 9, 2026 | Liddy Anne M. · officer: General Counsel | A-Award | 3,452 | $0.00 |
| Apr 9, 2026 | Mitchell Essex D · officer: Chief Operating Officer | A-Award | 46,154 | $0.00 |
| Apr 9, 2026 | Verstreken Jan · officer: Group President, International | A-Award | 31,409 | $0.00 |
| Apr 9, 2026 | Schneiders Jennifer M · officer: President, Diag. Solutions | A-Award | 22,598 | $0.00 |
| Apr 9, 2026 | Schnittker Brandon · officer: President, GYN Surgical | A-Award | 8,432 | $0.00 |
| Mar 2, 2026 | HANTSON LUDWIG · director | A-Award | 3,190 | $0.00 |
| Mar 2, 2026 | Wendell Amy McBride · director | A-Award | 3,190 | $0.00 |
| Mar 2, 2026 | Madaus Martin D · director | A-Award | 3,190 | $0.00 |
| Mar 2, 2026 | McMillan Wayde D. · director | A-Award | 3,190 | $0.00 |
| Mar 2, 2026 | Liddy Anne M. · officer: General Counsel | F-InKind | 185 | $75 |
| Mar 2, 2026 | Stamoulis Christiana · director | A-Award | 3,190 | $0.00 |
| Mar 2, 2026 | Mohtashami Nanaz · director | A-Award | 3,190 | $0.00 |
| Mar 2, 2026 | Stewart Stacey D. · director | A-Award | 3,190 | $0.00 |
| Mar 2, 2026 | Dockendorff Charles J · director | A-Award | 3,190 | $0.00 |
| Feb 12, 2026 | Horvath Mark W. · officer: President, Breast & Skeletal | F-InKind | 113 | $75 |
| Feb 3, 2026 | De Walt Diana · officer: SVP, Human Resources | F-InKind | 4,416 | $75 |
| Dec 16, 2025 | Schnittker Brandon · officer: President, GYN Surgical | F-InKind | 90 | $75 |
| Nov 18, 2025 | Schneiders Jennifer M · officer: President, Diag. Solutions | F-InKind | 561 | $74 |
| Nov 18, 2025 | COHN BENJAMIN JORDAN · officer: Principal Accounting Officer | F-InKind | 187 | $74 |
| Nov 18, 2025 | Liddy Anne M. · officer: General Counsel | F-InKind | 337 | $74 |
| Nov 18, 2025 | Schnittker Brandon · officer: President, GYN Surgical | F-InKind | 178 | $74 |
| Nov 18, 2025 | MACMILLAN STEPHEN P · director, officer: Chairman, President and CEO | F-InKind | 6,874 | $74 |
| Nov 18, 2025 | Mitchell Essex D · officer: Chief Operating Officer | F-InKind | 1,342 | $74 |
| Nov 18, 2025 | Oberton Karleen Marie · officer: Chief Financial Officer | F-InKind | 1,333 | $74 |
| Nov 18, 2025 | Verstreken Jan · officer: Group President, International | F-InKind | 196 | $74 |
| Nov 12, 2025 | Mitchell Essex D · officer: Chief Operating Officer | F-InKind | 1,701 | $75 |
Institutional positioning
13F filings over the trailing two quarters
New 86Increased 254Reduced 238Sold out 696
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 22,520,444 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 14,503,914 | May 15, 2026 |
| STATE STREET CORP | Increased | 9,990,906 | May 15, 2026 |
| HBK INVESTMENTS L P | Increased | 9,800,000 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 9,620,600 | May 8, 2026 |
| FIL LTD | Increased | 7,821,581 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 6,058,845 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 5,656,425 | May 15, 2026 |
| UBS GROUP AG | Increased | 5,089,745 | May 5, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 4,722,968 | May 15, 2026 |
| PENTWATER CAPITAL MANAGEMENT LP | Increased | 4,500,224 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 3,573,011 | May 15, 2026 |
| GLAZER CAPITAL, LLC | Increased | 3,563,652 | May 14, 2026 |
| JPMORGAN CHASE & CO | Increased | 3,301,493 | May 13, 2026 |
| INVESCO LTD. | Reduced | 3,164,586 | May 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 9, 2026